Exploring the trend in referrals for consideration of CRS and HIPEC to understand the attitudes of clinicians in the development of a national cancer centre programme in peritoneal disease

References

• Sadeghi B, Arvieux C, Glehen O, et al. (2000). Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88:358–63.
   PubMed Web of Science ®Google Scholar
• Verwaal VJ, Bruin S, Boot H, et al. (2008). 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15:2426–32.
   PubMed Web of Science ®Google Scholar
• Razenberg LG, van Gestel YR, Creemers GJ, et al. (2015). Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands. Eur J Surg Oncol 41:466–71.
   PubMed Web of Science ®Google Scholar
• Teo MC, Tan GH, Tham CK, et al. (2013). Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution. Ann Surg Oncol 20:2968–74.
   PubMed Web of Science ®Google Scholar
• Wong JF, Tan GH, Wang W, et al. (2015). Repeat cytoreductive surgery and HIPEC for peritoneal surface malignancy and peritoneal carcinomatosis. World J Surg 39:1578–1583.
   PubMed Web of Science ®Google Scholar
• Glockzin G, Schlitt HJ, Piso P. (2009). Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 7:5.
   PubMed Web of Science ®Google Scholar
• Esquivel J. (2010). Current status of colorectal cancer with peritoneal carcinomatosis. Ann Surg Oncol 17:1968–9.
   PubMed Web of Science ®Google Scholar
• Mirnezami R, Mehta AM, Chandrakumaran K, et al. (2014). Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone. Br J Cancer 111:1500–8.
   PubMed Web of Science ®Google Scholar
• Tan GH, Cheung M, Chanyaputhipong J, et al. (2013). Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma. Ann Acad Med Singapore 42:291–6.
   PubMed Web of Science ®Google Scholar
• Jayne DG, Fook S, Loi C, Seow-Choen F. (2002). Peritoneal carcinomatosis from colorectal cancer. Br J Surg 89:1545–50.
   PubMed Web of Science ®Google Scholar
• Quere P, Facy O, Manfredi S, et al. (2015). Epidemiology, management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study. Dis Colon Rectum 58:743–52.
   PubMed Web of Science ®Google Scholar
• Teo MC, Ching Tan GH, Lim C, et al. (2015). Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center. Asian J Surg/Asian Surg Assoc 38:65–73.
   PubMed Web of Science ®Google Scholar
• Teo MC. (2014). Update on the management and the role of intraperitoneal chemotherapy for ovarian cancer. Curr Opin Obstet Gynecol 26:3–8.
   PubMed Web of Science ®Google Scholar
• Pilati P, Rossi CR, Mocellin S, et al. (2001). Multimodal treatment of peritoneal carcinomatosis and sarcomatosis. Eur J Surg Oncol 27:125–34.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH. (1998). Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14:254–61.
   PubMedGoogle Scholar
• Sugarbaker PH. (1999). Management of peritoneal-surface malignancy: the surgeon’s role. Langenbeck’s Arch Surg/Deutsche Gesellschaft Fur Chirurgie 384:576–87.
   PubMed Web of Science ®Google Scholar
• Sugarbaker PH, Mora JT, Carmignani P, et al. (2005). Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. The Oncologist 10:112–22.
   PubMed Web of Science ®Google Scholar
• Chan AW, Munene G, Weaver J, et al. (2013). Cytoreductive strategies in the treatment of carcinomatosis of colorectal origin: results of a transdisciplinary national survey. Open Surg Oncol J 4:1–6.
   Google Scholar
• Braam HJ, Boerma D, Wiezer MJ, van Ramshorst B. (2015). Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists. Int J Clin Oncol 20:928–934.
   PubMed Web of Science ®Google Scholar
• Roviello F, Pinto E, Corso G, et al. (2010). Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer. J Surg Oncol 102:663–70.
   PubMed Web of Science ®Google Scholar
• Bijelic L, Jonson A, Sugarbaker PH. (2007). Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 18:1943–50.
   PubMed Web of Science ®Google Scholar
• Makrin V, Lev-Chelouche D, Even Sapir E, et al. (2005). Intraperitoneal heated chemotherapy affects healing of experimental colonic anastomosis: an animal study. J Surg Oncol 89:18–22.
   PubMed Web of Science ®Google Scholar
• Haslinger M, Francescutti V, Attwood K, et al. (2013). A contemporary analysis of morbidity and outcomes in cytoreduction/hyperthermic intraperitoneal chemoperfusion. Cancer Med 2:334–42.
   PubMed Web of Science ®Google Scholar
• Glehen O, Osinsky D, Cotte E, et al. (2003). Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 10:863–9.
   PubMed Web of Science ®Google Scholar
• Stephens AD, Alderman R, Chang D, et al. (1999). Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6:790–6.
   PubMed Web of Science ®Google Scholar
• Hadi R, Saunders V, Utkina O, et al. (2006). Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy. ANZ J Surg 76:156–61.
   PubMed Web of Science ®Google Scholar
• Tan GH, Ong WS, Chia CS, et al. (2016). Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference? Int J Hyperthermia 32:281–8.
   PubMed Web of Science ®Google Scholar
• Dube P, Sideris L, Law C, et al. (2015). Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms. Curr Oncol (Toronto, ON) 22:e100–12.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Cervantes A, Nordlinger B, Arnold D. (2014). Metastatic colorectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):iii1–9.
   PubMed Web of Science ®Google Scholar
• Chia CS, You B, Decullier E, et al. (2016). Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility? Ann Surg Oncol 23:1971–9.
   PubMed Web of Science ®Google Scholar
• Rudloff U, Langan R, Mullinax JE, et al. (2014). Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol 110:275–84.
   PubMed Web of Science ®Google Scholar
• van Oudheusden TR, Braam HJ, Luyer MD, et al. (2015). Peritoneal cancer patients not suitable for cytoreductive surgery and HIPEC during explorative surgery: risk factors, treatment options, and prognosis. Ann Surg Oncol 22:1236–42.
   PubMed Web of Science ®Google Scholar
• Iversen LH, Rasmussen PC, Laurberg S. (2013). Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100:285–92.
   PubMed Web of Science ®Google Scholar
• Turlakow A, Yeung HW, Salmon AS, et al. (2003). Peritoneal carcinomatosis: role of (18)F-FDG PET. J Nuclear Med 44:1407–12.
   PubMed Web of Science ®Google Scholar
• Low RN. (2016). Preoperative and surveillance MR imaging of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. J Gastrointestinal Oncol 7:58–71.
   PubMed Web of Science ®Google Scholar
• Marmor RA, Kelly KJ, Lowy AM, Baumgartner JM. (2016). Laparoscopy is safe and accurate to evaluate peritoneal surface metastasis prior to cytoreductive surgery. Ann Surg Oncol 23:1461–7.
   PubMed Web of Science ®Google Scholar
• Mittal RA-O, Chandramohan A, Moran B. (2017). Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia 33:511–19.
   PubMed Web of Science ®Google Scholar